The Foundation For Homeopathic Education

Restricted Access
Private Foundation
FAIRFAX, VirginiaMicroEIN: 813120524
Research InstitutionsHealth Charities

This organization is a private foundation focused on supporting medical research, particularly in the field of homeopathy. It aims to advance health-related educational and research initiatives, primarily through grants to institutions involved in medical education and research. The foundation has made contributions to organizations such as Drexel University College and the Homeopathic Pharmacopoeia of the United States. While it operates on a small scale, its funding is directed towards enhancing the understanding and application of homeopathic practices.

Source: Zeffy Agent · Mar 2026

Ideal Applicant

An established institutional medical research or health charity (often with an academic or professional footprint in Pennsylvania) that might be identified and invited by the foundation or its network.

Good Fit

  • Organizational profile as a research institution or medical school with track record in clinical or medical research.
  • Presence in Pennsylvania or demonstrated programmatic work in PA.
  • Existing relationships or visibility to the foundation's officers or their professional networks.
  • Capacity to receive and manage single-year institutional grants in the $5K–$25K range.

Geography

Restrictive

Observed grants in both years went to recipients located in Pennsylvania only, indicating a narrow geographic footprint in the available history.

Recipient Variety

Restrictive

The latest year shows a single recipient and each observed year contains only one grant; over two years two different institutional recipients were funded, so the observed recipient set is very small.

New Applicants

Restrictive

Filings and the default application entry state that the foundation funds only preselected applicants and there is no public application or contact route; with two years of single, invitation-like grants, direct evidence that unfamiliar applicants can readily enter the portfolio is weak.

Source: Zeffy Agent · Mar 2026